Experience with trametinib in a pediatric patient with MAP2K1-related cervicofacial arteriovenous malformation.
Saved in:
| Title: | Experience with trametinib in a pediatric patient with MAP2K1-related cervicofacial arteriovenous malformation. |
|---|---|
| Authors: | Swaminathan N; Department of Pediatrics, Pediatric Hematology Oncology, University of Michigan, Ann Arbor, Michigan, USA., Smith JD; Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, USA., Parmar HA; Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA., Gemmete JJ; Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, USA.; Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.; Department of Neurosurgery, University of Michigan, Ann Arbor, Michigan, USA., Pipe SW; Department of Pediatrics and Pathology, University of Michigan, Ann Arbor, Michigan, USA., Zopf DA; Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan, USA. |
| Source: | Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Nov; Vol. 71 (11), pp. e31298. Date of Electronic Publication: 2024 Aug 27. |
| Publication Type: | Case Reports; Letter |
| Journal Info: | Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1545-5017 |
|---|---|
| DOI: | 10.1002/pbc.31298 |
